Autopsy report · NCT01548144

Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer

“PI request”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 9 years 4 months before it stopped.
• 178 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

M.D. Anderson Cancer Center

Sponsor type

University, hospital or other

Conditions

Advanced Cancers

Interventions

Crizotinib (Xalkori); Pazopanib; Pemetrexed

Participants

178

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.